srael-based Bendit Technologies’ steerable microcatheter has gained clearance from the US Food and Drug Administration (FDA), providing US clinicians with a new option for particularly intricate vascular procedures.

The Bendit17 microcatheter can be navigated with or without a guidewire. It is underpinned by Bendit’s proprietary real-time 3D steering technology and is intended to give clinicians greater control during neurovascular and peripheral endovascular interventions, according to the company.

Claimed to become the smallest microcatheter available on the US market, Bendit17 is poised to undertake its first commercial clinical procedures in the US in January 2026. In parallel, the company said it is actively pursuing additional regulatory clearances in other global territories.